| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 19, 2025 | EyePoint Pharmaceuticals, Inc. | Director | Buy | 95.0 | +10,000 | 37.74% | ✗ | $59K |
| May 14, 2025 | May 15, 2025 | EyePoint Pharmaceuticals, Inc. | Director | Buy | 95.0 | +10,000 | 60.61% | ✗ | $54.5K |
| Aug 19, 2024 | Aug 21, 2024 | EyePoint Pharmaceuticals, Inc. | Director | Buy | 95.0 | +12,500 | 312.50% | ✗ | $99.8K |
| Mar 16, 2024 | Mar 25, 2024 | Axogen, Inc. | CEO | Sell | 40.0 | -39,280 | -1.14% | ✗ | $301.7K |
| Jul 18, 2022 | Jul 20, 2022 | Axogen, Inc. | CEO | Sell | 72.5 | +12,995 | 0.66% | ✗ | $76.3K |
| Dec 27, 2021 | Dec 29, 2021 | Axogen, Inc. | CEO | Sell | 51.3 | -1,752 | -0.19% | ✗ | $17.1K |
| Dec 20, 2021 | Dec 22, 2021 | Axogen, Inc. | CEO | Sell | 51.3 | -1,243 | -0.13% | ✗ | $11.5K |
| Aug 10, 2021 | Aug 10, 2021 | Axogen, Inc. | CEO | Sell | 35.0 | -41,000 | -4.80% | ✓ | $757.2K |
| Jul 19, 2021 | Jul 21, 2021 | Axogen, Inc. | CEO | Sell | 82.5 | +13,265 | 1.73% | ✗ | $169.2K |
| Feb 16, 2021 | Feb 18, 2021 | Axogen, Inc. | CEO | Sell | 72.5 | +22,313 | 0.90% | ✗ | $143.8K |
| Jan 8, 2021 | Jan 12, 2021 | Axogen, Inc. | CEO | Sell | 23.8 | -65,000 | -9.64% | ✓ | $1.3M |
| Dec 27, 2020 | Dec 30, 2020 | Axogen, Inc. | CEO | Sell | 72.5 | +5,300 | 0.79% | ✗ | $62.3K |
| Dec 18, 2020 | Dec 22, 2020 | Axogen, Inc. | CEO | Sell | 61.3 | +1,850 | 0.29% | ✗ | $20.9K |
| Nov 9, 2020 | Nov 10, 2020 | Axogen, Inc. | CEO | Sell | 41.3 | -14,000 | -2.12% | ✓ | $203.4K |
| Feb 18, 2020 | Feb 20, 2020 | Axogen, Inc. | CEO | Sell | 87.5 | +24,564 | 3.94% | ✗ | $79.7K |
| Jan 1, 2020 | Jan 17, 2020 | Axogen, Inc. | CEO | Sell | 90.0 | +29,888 | 5.04% | ✗ | $175.3K |
| Aug 9, 2019 | Aug 12, 2019 | Axogen, Inc. | CEO | Buy | 100.0 | +75,000 | 14.47% | ✗ | $1M |
| Nov 19, 2018 | Nov 21, 2018 | Axogen, Inc. | CEO | Sell | 22.5 | -6,761 | -1.49% | ✗ | $191.8K |
| Nov 13, 2018 | Nov 15, 2018 | Axogen, Inc. | CEO | Sell | 20.0 | -25,000 | -6.13% | ✗ | $829.6K |
| Aug 7, 2018 | Aug 9, 2018 | Axogen, Inc. | CEO | Sell | 20.0 | -10,060 | -2.41% | ✗ | $395.4K |
| Oct 7, 2016 | Oct 14, 2016 | Axogen, Inc. | CEO | Buy | 87.5 | +10,000 | 4.31% | ✗ | $75K |
| May 27, 2015 | May 29, 2015 | Axogen, Inc. | CEO | Buy | 78.8 | +3,325 | 1.45% | ✗ | $10.5K |
| Jun 3, 2014 | Jun 4, 2014 | Axogen, Inc. | CEO | Buy | 78.8 | +5,000 | 1.52% | ✗ | $12.2K |
| May 12, 2014 | May 13, 2014 | Axogen, Inc. | CEO | Buy | 78.8 | +5,000 | 1.54% | ✗ | $13.5K |
| Mar 13, 2014 | Mar 17, 2014 | Axogen, Inc. | CEO | Buy | 77.5 | +1,500 | 1.11% | ✗ | $5.2K |
| Aug 14, 2013 | Aug 15, 2013 | Axogen, Inc. | CEO | Buy | 86.3 | +8,334 | 6.90% | ✗ | $25K |
| Dec 10, 2012 | Dec 13, 2012 | Axogen, Inc. | CEO | Buy | 67.5 | +900 | 0.75% | ✗ | $2.3K |
| Nov 20, 2012 | Nov 23, 2012 | Axogen, Inc. | CEO | Buy | 55.0 | +100 | 0.08% | ✗ | $269 |